← Open Payments lookup

IBUKUNOLUWA AYANLEYE: Open Payments

NPI 1265138853 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,317 in 124 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,280 · 2025 $3,317

Food & beverage: $3,086Education: $231
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$503
Otsuka America Pharmaceutical, Inc.10$402
ABBVIE INC.14$327
E.R. Squibb & Sons, L.L.C.12$296
Lundbeck LLC15$289
Janssen Pharmaceuticals, Inc10$276
Neurocrine BioSciences, Inc.7$273
Axsome Therapeutics, Inc.8$212
Supernus Pharmaceuticals, Inc.6$174
Alkermes, Inc.11$167

Products named: ABILIFY MAINTENA, VRAYLAR, COBENFY, INVEGA SUSTENNA, INGREZZA, AUSTEDO XR, Auvelity, REXULTI.

Industry payments across MD — which companies pay providers there.